Sun Pharmaceutical Industries
BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01028 | Pharmaceuticals
Profit & Loss account of Sun Pharmaceutical Industries |
------------------- in Rs. Cr. ------------------- |
|
Mar '05 |
Mar '06 |
Mar '07 |
Mar '08 |
Mar '09 |
 |
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Income |
|
|
|
|
| Sales Turnover |
1,056.01 |
1,353.01 |
1,722.13 |
2,427.35 |
2,833.65 |
| Excise Duty |
48.73 |
61.37 |
59.57 |
58.84 |
59.00 |
| Net Sales |
1,007.28 |
1,291.64 |
1,662.56 |
2,368.51 |
2,774.65 |
| Other Income |
232.87 |
525.55 |
750.26 |
914.83 |
1,276.22 |
| Stock Adjustments |
-0.45 |
57.23 |
41.41 |
17.38 |
23.78 |
| Total Income |
1,239.70 |
1,874.42 |
2,454.23 |
3,300.72 |
4,074.65 |
| Expenditure |
|
|
|
|
| Raw Materials |
563.75 |
899.67 |
1,214.48 |
1,564.61 |
1,961.89 |
| Power & Fuel Cost |
14.48 |
25.55 |
31.14 |
37.36 |
50.44 |
| Employee Cost |
82.78 |
82.01 |
98.87 |
120.20 |
148.31 |
| Other Manufacturing Expenses |
24.97 |
23.11 |
25.08 |
35.21 |
43.93 |
| Selling and Admin Expenses |
163.72 |
287.47 |
370.20 |
415.35 |
494.98 |
| Miscellaneous Expenses |
37.10 |
15.97 |
18.85 |
14.62 |
18.06 |
| Preoperative Exp Capitalised |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Expenses |
886.80 |
1,333.78 |
1,758.62 |
2,187.35 |
2,717.61 |
|
Mar '05 |
Mar '06 |
Mar '07 |
Mar '08 |
Mar '09 |
|
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Operating Profit |
120.03 |
15.09 |
-54.65 |
198.54 |
80.82 |
| PBDIT |
352.90 |
540.64 |
695.61 |
1,113.37 |
1,357.04 |
| Interest |
0.00 |
11.23 |
8.80 |
5.06 |
2.77 |
| PBDT |
352.90 |
529.41 |
686.81 |
1,108.31 |
1,354.27 |
| Depreciation |
32.83 |
40.73 |
46.27 |
56.11 |
58.86 |
| Other Written Off |
2.45 |
0.00 |
0.00 |
0.00 |
0.00 |
| Profit Before Tax |
317.62 |
488.68 |
640.54 |
1,052.20 |
1,295.41 |
| Extra-ordinary items |
12.45 |
0.00 |
-0.05 |
0.00 |
11.70 |
| PBT (Post Extra-ord Items) |
330.07 |
488.68 |
640.49 |
1,052.20 |
1,307.11 |
| Tax |
17.77 |
27.39 |
11.61 |
38.16 |
30.12 |
| Reported Net Profit |
305.71 |
461.29 |
628.93 |
1,014.04 |
1,265.29 |
| Total Value Addition |
323.05 |
434.11 |
544.14 |
622.74 |
755.72 |
| Preference Dividend |
0.08 |
0.08 |
0.08 |
0.05 |
0.00 |
| Equity Dividend |
69.57 |
102.30 |
130.01 |
217.47 |
284.79 |
| Corporate Dividend Tax |
9.91 |
14.36 |
18.25 |
37.20 |
48.40 |
| Per share data (annualised) |
|
|
|
|
| Shares in issue (lakhs) |
1,855.11 |
1,857.32 |
1,934.02 |
2,071.16 |
2,071.16 |
| Earning Per Share (Rs) |
16.48 |
24.83 |
32.52 |
48.96 |
61.09 |
| Equity Dividend (%) |
75.00 |
110.00 |
135.00 |
210.00 |
275.00 |
| Book Value (Rs) |
59.51 |
78.80 |
126.58 |
203.15 |
248.72 |
|
|
|
|
| Source : Religare Technova |
| Explore Sun Pharma connections |
|
